NS Investment

NS Investment

NS Investment

MedCity News

Harpoon Therapeutics raises $70M Series C for T-cell engager therapies

$70,000,000 Venture capital (Series C)
PE Hub

Harpoon Therapeutics snags $70 mln Series C

$60,000,000 IPO
PE Hub

VC-backed Constellation Pharmaceuticals rolls out IPO

Stock markets Funding Health
$15,000,000 Venture capital (Series C)
FinSMEs

Antiva Biosciences Closes $15M Series C-1 Financing

Funding Health
$100,000,000 Venture capital
FinSMEs , PE Hub

Constellation Pharmaceuticals Raises $100M Financing

Funding Health Science
$50,000,000 Venture capital (Series C)
FinSMEs

ORIC Pharmaceuticals Raises $50M Series C Financing

Funding Health
PE Hub

Harpoon Therapeutics raises $45 mln from Arix, New Leaf, others

Funding
$22,000,000 Venture capital (Series C)
vcnewsdaily , antivabio , FinSMEs

Antiva Biosciences Closes $22M Series

PE Hub

Antiva Biosciences bags $22 mln Series C

Funding Messaging
PE Hub

VC-backed Harpoon Therapeutics appoints McMahon as president and CEO - PE Hub

Health Strategy Funding
$55,000,000 Venture capital
Xconomy

With Drugs in Clinic, Constellation Nabs $55M For IPO Push

Funding Health
Xconomy

Constellation Pharma Plots IPO Run As Genentech Passes on Buyout Deal

Health